Skip to content
GenoLensGenoLens

PPT1

Chr 1p34.2

palmitoyl-protein thioesterase 1

Aliases:
CLN1, INCL
MANE:
ENST00000642050.2

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Lysosomal storage disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Neuronal ceroid lipofuscinosis

    BIALLELIC, autosomal or pseudoautosomal
  • Retinal disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal

+7 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • neuronal ceroid lipofuscinosis 1

    0.84
  • neuronal ceroid lipofuscinosis

    0.68
  • CLN1 disease

    0.59
  • hereditary disease

    0.53
  • Alzheimer disease

    0.48
  • Parkinson disease

    0.48
  • infantile neuronal ceroid lipofuscinosis

    0.47
  • lysosomal storage disease

    0.46
  • neurodegenerative disease

    0.46
  • multiple sclerosis

    0.46

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Palmitoyl-protein thioesterase 1

Has thioesterase activity against fatty acid thioesters with 14 -18 carbons, including palmitoyl-CoA, S-palmitoyl-N-acetylcysteamine, and palmitoylated proteins (PubMed:12855696, PubMed:26731412, PubMed:8816748). In contrast to PPT2, PPT1 can hydrolyze palmitoylated proteins and palmitoylcysteine (PubMed:12855696)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.